NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Beijing WellGene Biotech Co., Ltd.

Beijing WellGene Biotech Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://genevec.com/

Last Round

Series C

May 22, 2023

Total Funding Raised

$58.01M

Company Overview

Beijing WellGene Biotech Co., Ltd. is a biotechnology company that develops gene therapy drugs and oncolytic virus therapies for the treatment of tumors, skin diseases, and other rare or refractory conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyoncolytic virusHSV-1viral vectorbiopharmaceuticalgene replacementsolid tumor treatmentepidermolysis bullosaCDMOCRObiotech startupclinical stage biotechdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beijing WellGene Biotech Co., Ltd. Comparables

Compare Beijing WellGene Biotech Co., Ltd. with similar companies based on industry and business-model similarity.

Beijing WellGene Biotech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ImmVira
85%
Virogin Biotech
85%
Wuhan Binhui Biopharmaceutical Co., Ltd.
81%

Beijing WellGene Biotech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMay 22, 2023
Series BNov 1, 2020
Series ASep 1, 2019

Beijing WellGene Biotech Co., Ltd. Investors

Notable investors and investment history

Beijing WellGene Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Beijing WellGene Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beijing WellGene Biotech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Year Founded2016
Last FundingMay 22, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.